PROFILE

This presentation discusses key considerations in the development of rare disease therapeutics, with a particular focus on the Korean regulatory and review framework for advanced biopharmaceuticals. It highlights major considerations in quality, nonclinical, and clinical evaluation, as well as regulatory pathways designed to facilitate timely access to innovative therapies while ensuring their quality, safety, and efficacy.